title: Systemic sclerosis complicated by procainamide-induced lupus and antiphospholipid syndrome.
authors.affiliation: Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Kameda
authors.forename: T
authors.initials: T
authors.lastname: Mimori
authors.forename: J
authors.initials: J
authors.lastname: Kaburaki
authors.forename: T
authors.initials: T
authors.lastname: Fujii
authors.forename: T
authors.initials: T
authors.lastname: Takahashi
authors.forename: M
authors.initials: M
authors.lastname: Akaishi
authors.forename: Y
authors.initials: Y
authors.lastname: Ikeda
mesh_terms: D000889:Anti-Arrhythmia Agents / Q000009:adverse effects*; D016736:Antiphospholipid Syndrome / Q000139:chemically induced* / Q000473:pathology; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D005534:Foot Diseases / Q000473:pathology; D005734:Gangrene / Q000473:pathology; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D010198:Pancytopenia / Q000139:chemically induced; D011342:Procainamide / Q000009:adverse effects*; D012595:Scleroderma, Systemic / Q000150:complications*; D013577:Syndrome; D014034:Toes / Q000473:pathology
chemical_list: D000889:Anti-Arrhythmia Agents; D011342:Procainamide